EP1240358A4 - Ligand ii de type recepteur t1 et utilisations de ce dernier - Google Patents

Ligand ii de type recepteur t1 et utilisations de ce dernier

Info

Publication number: EP1240358A4
Authority: EP; European Patent Office
Prior art keywords: ligand; receptor
Prior art date: 1999-12-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00984100A

Other languages

German (de)

English (en)

Other versions

EP1240358A1 (fr

Inventor

Jian Ni

Reiner L Gentz

Steven M Ruben

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Human Genome Sciences Inc

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-10

Filing date

2000-12-08

Publication date

2005-10-19

2000-12-08 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2002-09-18 Publication of EP1240358A1 publication Critical patent/EP1240358A1/fr

2005-10-19 Publication of EP1240358A4 publication Critical patent/EP1240358A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Cell Biology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Pathology (AREA)
Toxicology (AREA)
Microbiology (AREA)
Marine Sciences & Fisheries (AREA)
Food Science & Technology (AREA)
Genetics & Genomics (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Peptides Or Proteins (AREA)

EP00984100A 1999-12-10 2000-12-08 Ligand ii de type recepteur t1 et utilisations de ce dernier Withdrawn EP1240358A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US16997999P	1999-12-10	1999-12-10
US169979P		1999-12-10
PCT/US2000/033389 WO2001042506A1 (fr)	1999-12-10	2000-12-08	Ligand ii de type recepteur t1 et utilisations de ce dernier

Publications (2)

Publication Number	Publication Date
EP1240358A1 EP1240358A1 (fr)	2002-09-18
EP1240358A4 true EP1240358A4 (fr)	2005-10-19

Family

ID=22618008

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00984100A Withdrawn EP1240358A4 (fr)	1999-12-10	2000-12-08	Ligand ii de type recepteur t1 et utilisations de ce dernier

Country Status (5)

Country	Link
EP (1)	EP1240358A4 (fr)
JP (1)	JP2003516164A (fr)
AU (1)	AU2077801A (fr)
CA (1)	CA2392742A1 (fr)
WO (1)	WO2001042506A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201013151D0 (en) *	2010-08-04	2010-09-22	Isis Innovation	Diagnostic method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998007754A1 (fr) *	1996-08-23	1998-02-26	Human Genome Sciences, Inc.	Ligand ii du type recepteur de t1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU643427B2 (en) *	1988-10-31	1993-11-18	Immunex Corporation	Interleukin-4 receptors

2000
- 2000-12-08 JP JP2001544377A patent/JP2003516164A/ja not_active Withdrawn
- 2000-12-08 AU AU20778/01A patent/AU2077801A/en not_active Abandoned
- 2000-12-08 WO PCT/US2000/033389 patent/WO2001042506A1/fr not_active Ceased
- 2000-12-08 EP EP00984100A patent/EP1240358A4/fr not_active Withdrawn
- 2000-12-08 CA CA002392742A patent/CA2392742A1/fr not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998007754A1 (fr) *	1996-08-23	1998-02-26	Human Genome Sciences, Inc.	Ligand ii du type recepteur de t1

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GAYLE M A ET AL: "CLONING OF A PUTATIVE LIGAND FOR THE T1/ST2 RECEPTOR", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 271, no. 10, 8 March 1996 (1996-03-08), pages 5784 - 5789, XP002065938, ISSN: 0021-9258 *
See also references of WO0142506A1 *

Also Published As

Publication number	Publication date
CA2392742A1 (fr)	2001-06-14
EP1240358A1 (fr)	2002-09-18
WO2001042506A1 (fr)	2001-06-14
JP2003516164A (ja)	2003-05-13
WO2001042506A9 (fr)	2002-08-22
AU2077801A (en)	2001-06-18

Publication	Publication Date	Title
HUP0200740A3 (en)	2004-08-30	Estrogen receptor-betha ligands and their use
EP1085837A4 (fr)	2004-06-02	Dispositif de fermeture de perforations dans le systeme vasculaire
AP2002002441A0 (en)	2002-03-31	Arylmethyl-carbonyla minothiazole derivates and their use as antitumor agents
EP1146790A4 (fr)	2004-03-17	Composes et procedes
EP1223932A4 (fr)	2003-01-15	Composes et methodes
HRP20060251B1 (hr)	2016-08-12	Supstituirani oksazolidinoni i njihova uporaba
PL356066A1 (en)	2004-06-14	Caspase inhibitors and uses thereof
GB0007842D0 (en)	2000-05-17	Sigma receptor ligands and their medical uses
HUP0203896A3 (en)	2003-05-28	Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB9930801D0 (en)	2000-02-16	Spreading factor determination
EP1056777A4 (fr)	2003-02-19	Recepteurs de ligands et leurs utilisations
GB9919689D0 (en)	1999-10-20	Back-lighting arrangement and the like
GB9903647D0 (en)	1999-04-07	Mat
GB2352523B (en)	2003-07-09	Fluid-gauging systems and methods
GB2363658B (en)	2004-02-18	Gaming systems and methods
GB9907687D0 (en)	1999-05-26	Assays methods and means
EP0963205A4 (fr)	2002-10-02	Ligand ii du type recepteur de t1
AU6913100A (en)	2001-03-13	Notch receptor ligands and uses thereof
EP1240358A4 (fr)	2005-10-19	Ligand ii de type recepteur t1 et utilisations de ce dernier
GB0021915D0 (en)	2000-10-25	Creating and managing E-receipts
GB9904880D0 (en)	1999-04-28	Recreational mat component
GB9929581D0 (en)	2000-02-09	Comjpositions and their use
EP0958374A4 (fr)	2004-11-17	Ligand i du type recepteur de t1
GB9927157D0 (en)	2000-01-12	Releasable Ligand
GB9920116D0 (en)	1999-10-27	Combination mat and bag

Legal Events

Date	Code	Title	Description
2002-08-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-09-18	17P	Request for examination filed	Effective date: 20020710
2002-09-18	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2002-09-18	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2005-10-19	A4	Supplementary search report drawn up and despatched	Effective date: 20050901
2006-04-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2006-05-31	18D	Application deemed to be withdrawn	Effective date: 20051108